Spectrum Pharmaceuticals Inc (SPPI)

4.60
0.01 0.22
NASDAQ : Health Care
Prev Close 4.61
Open 4.61
Day Low/High 4.51 / 4.62
52 Wk Low/High 4.14 / 7.74
Volume 331.95K
Avg Volume 773.90K
Exchange NASDAQ
Shares Outstanding 80.56M
Market Cap 366.54M
EPS -0.80
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Spectrum Pharmaceuticals Highlights Survival Advantage In A Case Match Control Analysis Of The PROPEL Study With FOLOTYN® (pralatrexate Injection) at The 58th Annual Meeting Of The American Society Of Hematology (ASH)

Spectrum Pharmaceuticals Highlights Survival Advantage In A Case Match Control Analysis Of The PROPEL Study With FOLOTYN® (pralatrexate Injection) at The 58th Annual Meeting Of The American Society Of Hematology (ASH)

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology announced the presentation of data from a...

Spectrum Pharmaceuticals Highlights Five Abstracts On ROLONTIS™ (eflapegrastim) And Poziotinib At The San Antonio Breast Cancer Symposium (SABCS) In San Antonio, Texas, December 6-10, 2016

Spectrum Pharmaceuticals Highlights Five Abstracts On ROLONTIS™ (eflapegrastim) And Poziotinib At The San Antonio Breast Cancer Symposium (SABCS) In San Antonio, Texas, December 6-10, 2016

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology, today announced key presentations of...

Spectrum Pharmaceuticals Highlights Four Abstracts At The 58th Annual Meeting Of The American Society Of Hematology (ASH) In San Diego, California, December 3-6, 2016

Spectrum Pharmaceuticals Highlights Four Abstracts At The 58th Annual Meeting Of The American Society Of Hematology (ASH) In San Diego, California, December 3-6, 2016

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology, today announced key presentations of...

Deadline Alert: Law Offices Of Howard G. Smith Reminds Investors Of The Upcoming November 21st Deadline In The Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc.

Deadline Alert: Law Offices Of Howard G. Smith Reminds Investors Of The Upcoming November 21st Deadline In The Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc.

Law Offices of Howard G. Smith reminds investors of the upcoming  November 21, 2016 deadline to file a lead plaintiff motion in the class action lawsuit filed on behalf of investors who purchased or otherwise...

Spectrum Pharmaceuticals Announces Poziotinib Data Presentation At The 17th IASLC World Conference On Lung Cancer In Vienna, Austria, December 4-7, 2016

Spectrum Pharmaceuticals Announces Poziotinib Data Presentation At The 17th IASLC World Conference On Lung Cancer In Vienna, Austria, December 4-7, 2016

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology, today announced that scientists from MD...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Spectrum Pharmaceuticals, Inc. Of Commencement Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of November 21, 2016

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Spectrum Pharmaceuticals, Inc. Of Commencement Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of November 21, 2016

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Spectrum Pharmaceuticals, Inc.

INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc. And Encourages Investors With Losses To Contact The Firm

INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc. And Encourages Investors With Losses To Contact The Firm

Khang & Khang LLP (the "Firm") announces a class action lawsuit against Spectrum Pharmaceuticals, Inc.

Spectrum Pharmaceuticals Provides Third Quarter Financial Update

Spectrum Pharmaceuticals Provides Third Quarter Financial Update

Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology announced today financial results for...

SPPI SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notifies Shareholders Of A Class Action Involving Spectrum Pharmaceuticals, Inc. And A Lead Plaintiff Deadline Of November 21, 2016

SPPI SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notifies Shareholders Of A Class Action Involving Spectrum Pharmaceuticals, Inc. And A Lead Plaintiff Deadline Of November 21, 2016

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of Nevada on behalf of investors who purchased Spectrum Pharmaceuticals, Inc.

SHAREHOLDER ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc. And Encourages Investors With Losses To Contact The Firm

SHAREHOLDER ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc. And Encourages Investors With Losses To Contact The Firm

Goldberg Law PC, a national shareholder rights litigation firm, announces a class action lawsuit has been filed against Spectrum Pharmaceuticals, Inc.

SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc. And Encourages Investors With Losses To Contact The Firm

SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc. And Encourages Investors With Losses To Contact The Firm

Khang & Khang LLP (the "Firm") announces a class action lawsuit against Spectrum Pharmaceuticals, Inc.

Spectrum Pharmaceuticals Provides Third Quarter Financial And Pipeline Update

Spectrum Pharmaceuticals Provides Third Quarter Financial And Pipeline Update

Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology announced that the earnings...

GPM Reminds Investors Of The November 21st Deadline In The Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc. And Encourages Investors To Contact The Firm

GPM Reminds Investors Of The November 21st Deadline In The Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc. And Encourages Investors To Contact The Firm

Glancy Prongay & Murray LLP ("GPM") reminds investors of the November 21, 2016 deadline to file a lead plaintiff motion in the class action lawsuit filed on behalf of investors who purchased or otherwise...

Tax-Loss Selling Offers Stock-Picking Opportunities

Our screen reveals 17 names that could become oversold and disconnected from their fundamentals as a result of this phenomenon.

Spectrum Pharmaceuticals Announces Third Quarter 2016 Financial Results Teleconference And Webcast

Spectrum Pharmaceuticals Announces Third Quarter 2016 Financial Results Teleconference And Webcast

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology, today announced it will host a...

Cohen Milstein Sellers & Toll PLLC Announces Investigation Of Spectrum Pharmaceuticals, Inc.

Cohen Milstein Sellers & Toll PLLC Announces Investigation Of Spectrum Pharmaceuticals, Inc.

Cohen Milstein Sellers & Toll PLLC is conducting an investigation to determine whether Spectrum Pharmaceuticals, Inc.

Spectrum Pharmaceuticals Announces Appointment Of Luigi Lenaz, M.D., As Lead Director

Spectrum Pharmaceuticals Announces Appointment Of Luigi Lenaz, M.D., As Lead Director

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology, today announced that independent director...

Spectrum Pharmaceuticals Becomes Oversold (SPPI)

Spectrum Pharmaceuticals Becomes Oversold (SPPI)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

SPPI LOSS NOTICE: Rosen Law Firm Reminds Spectrum Pharmaceuticals, Inc. Investors Of Important Deadline In Class Action Filed By Firm - SPPI

SPPI LOSS NOTICE: Rosen Law Firm Reminds Spectrum Pharmaceuticals, Inc. Investors Of Important Deadline In Class Action Filed By Firm - SPPI

Rosen Law Firm, a global investor rights law firm, reminds purchasers of Spectrum Pharmaceuticals, Inc.

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Spectrum Pharmaceuticals, Inc. To Contact The Firm

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Spectrum Pharmaceuticals, Inc. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Spectrum Pharmaceuticals, Inc.

EQUITY ALERT: Rosen Law Firm Files Securities Class Action Against Spectrum Pharmaceuticals, Inc. - SPPI

EQUITY ALERT: Rosen Law Firm Files Securities Class Action Against Spectrum Pharmaceuticals, Inc. - SPPI

Rosen Law Firm, a global investor rights law firm, announces that it has filed a class action lawsuit on behalf of purchasers of Spectrum Pharmaceuticals, Inc.